| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
CA: A Cancer Journal for Clinicians, Vol 49, Issue 2 101-116, Copyright © 1999 by American Cancer Society
D. L. Morton, D. W. Ollila, E. C. Hsueh, R. Essner and R. K. Gupta
Although patients with metastatic disease are usually not offered surgery
as part of their comprehensive treatment plan, the authors suggest that
surgical reduction of the tumor burden may enhance the host immune response
and create a favorable setting for the use of active specific
immunotherapy.
ARTICLES
Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma
John Wayne Cancer Institute (JWCI), Saint John's Health Center, Santa Monica, CA, USA.
This article has been cited by other articles:
|
|
 |
|
  C. C. Lee, M. B. Faries, L. A. Wanek, and D. L. Morton Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary Melanoma J. Clin. Oncol., February 1, 2008; 26(4): 535 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Shakhar, N. Abudarham, R. Melamed, Y. Schwartz, E. Rosenne, and S. Ben-Eliyahu Amelioration of Operation-Induced Suppression of Marginating Pulmonary NK Activity using Poly IC: A Potential Approach to Reduce Postoperative Metastasis Ann. Surg. Oncol., February 1, 2007; 14(2): 841 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Faries and D. L. Morton The Promise of Metastasectomy in Melanoma Ann. Surg. Oncol., May 1, 2006; 13(5): 607 - 609. [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Faries, R. J. Bleicher, X. Ye, R. Essner, and D. L. Morton Lymphatic Mapping and Sentinel Lymphadenectomy for Primary and Metastatic Pulmonary Malignant Neoplasms Arch Surg, August 1, 2004; 139(8): 870 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Shakhar and S. Ben-Eliyahu Potential Prophylactic Measures Against Postoperative Immunosuppression: Could They Reduce Recurrence Rates in Oncological Patients? Ann. Surg. Oncol., October 1, 2003; 10(8): 972 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Sticca Peritoneal Carcinomatosis: A Final Frontier Ann. Surg. Oncol., June 1, 2003; 10(5): 484 - 485. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ng-Cashin, J. J. Kuhns, S. E. Burkett, J. D. Powderly, R. R. Craven, H. W. van Deventer, S. L. Kirby, and J. S. Serody Host Absence of CCR5 Potentiates Dendritic Cell Vaccination J. Immunol., April 15, 2003; 170(8): 4201 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Takeuchi, C. Kuo, D. L. Morton, H.-J. Wang, and D. S. B. Hoon Expression of Differentiation Melanoma-associated Antigen Genes Is Associated with Favorable Disease Outcome in Advanced-Stage Melanomas Cancer Res., January 15, 2003; 63(2): 441 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Hsueh, R. Essner, L. J. Foshag, D. W. Ollila, G. Gammon, S. J. O'Day, P. D. Boasberg, S. L. Stern, X. Ye, and D. L. Morton Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine J. Clin. Oncol., December 1, 2002; 20(23): 4549 - 4554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Hsueh, R. Essner, L. J. Foshag, W. Ye, and D. L. Morton Active Immunotherapy by Reinduction With a Polyvalent Allogeneic Cell Vaccine Correlates With Improved Survival in Recurrent Metastatic Melanoma Ann. Surg. Oncol., June 1, 2002; 9(5): 486 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Wood, L. A. DiFronzo, D. M. Rose, P. I. Haigh, S. L. Stern, L. Wanek, R. Essner, and D. L. Morton Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival? Ann. Surg. Oncol., September 1, 2001; 8(8): 658 - 662. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
